Phage translocation, safety and immunomodulation

Bacteriophages in Health and Disease

Volumn , Issue , 2012, Pages 168-184

  Olszowska Zaremba, Natasza ^a   Borysowski, Jan ^a   Dabrowska, Krystyna ^b   Górski, Andrzej ^b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84878308144     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (94)

1. Adair, B.D. and Yeager, M. (2002) Threedimensional model of the human platelet integrin αIIbβ3 based on electron cryomicroscopy and X-ray crystallography. Proceedings of the National Academy of Sciences USA 99, 14059-14064.
2. Adams, M.H. (1959) Antigenic properties. In: Adams, M.H. (ed.) Bacteriophages. Interscience Publishers, New York, NY, pp. 97-119.
3. Balzan, S., Quadros, C.A., Cleva, R., Zilberstein, B. and Cecconello, I. (2007) Bacterial translocation: overview of mechanisms and clinical impact. Journal of Gastroenterology and Hepatology 22, 464-471.
4. Bateman, A., Eddy, S.R. and Mesyanzhinov, V.V. (1997) A member of the immunoglobulin superfamily in bacteriophage T4. Virus Genes 14, 163-165.
5. Bearden, C.M., Agarwal, A., Book, B.K., Vieira, C.A., Sidner, R.A., Ochs, H.D., Young, M. and Pescovitz, M.D. (2005) Rituximab inhibits the in vivo primary and secondary antibody response to a neoantigen, bacteriophage φX174. American Journal of Transplantation 5, 50-57.
6. Berinstein, A., Roivainen, M., Hovi, T., Mason, P.W. and Baxt, B. (1995) Antibodies to the vitronectin receptor (integrin αVβ3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells. Journal of Virology 69, 2664-2666.
7. Blaser, M. (2011) Stop the killing of beneficial bacteria. Nature 476, 393-394.
8. Bloch, H. (1940) Experimental investigation on the relationships between bacteriophages and malignant tumors. Archives in Virology 1, 481-496 (in German).
9. Borysowski, J., Wierzbicki, P., Kłosowska, D., Korczak-Kowalska, G., Weber-Dabrowska, B. and Górski, A. (2010) The effects of T4 and A3/R phage preparations on whole-blood monocyte and neutrophil respiratory burst. Viral Immunology 23, 1-4.
10. Bradley, S.G., Kim, Y.B. and Watso, D.W. (1963) Immune response by the mouse to orally administered actinophage. Proceedings of the Society for Experimental Biology and Medicine 113, 686-688.
11. Bruttin, A. and Brüssow, H. (2005) Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy. Antimicrobial Agents and Chemotherapy 49, 2874-2878.
12. Chanishvili, N., Chanishvili, T., Tediashvili, M. and Barrow, P.A. (2001) Phages and their application against drug-resistant bacteria. Journal of Chemical Technology and Biotechnology 76, 689-699.
13. Dabrowska, K., Opolski, A., Wietrzyk, J., Świtała-Jeleń, K., Boratyński, J., Nasulewicz, A., Lipińska, L., Chybicka, A., Kujawa, M., Zabel, M., Dolińska-Krajewska, B., Piasecki, E., Weber-Dabrowska, B., Rybka, J., Salwa, J., Wojdat, E., Nowaczyk, M. and Górski, A. (2004) Antitumor activity of bacteriophages in murine experimental cancer models caused possibly by inhibition of β3 integrin signaling pathway. Acta Viriologica 48, 241-248.
14. Dabrowska, K., Świtała-Jeleń, K., Opolski, A., Weber-Dabrowska, B. and Górski, A. (2005) Bacteriophage penetration in vertebrates. Journal of Applied Microbiology 98, 7-13.
15. Dabrowska, K., Świtała-Jeleń, K., Opolski, A. and Górski, A. (2006) Possible association between phages, Hoc protein and the immune system. Archives of Virology 151, 209-215.
16. Dabrowska, K., Zembala, M., Boratyński, J., Świtała-Jeleń, K., Wietrzyk, J., Opolski, A., Szczaurska, K., Kujawa, M., Godlewska, J. and Górski, A. (2007) Hoc protein regulates the biological effects of T4 phage in mammals. Archives of Microbiology 187, 489-498.
17. Dabrowska, K., Skaradziński, G., Jończyk, P., Kurzepa, A., Wietrzyk, J., Owczarek, B., Zaczek, M., Świtała-Jeleń, K., Boratyński, J., Poźniak, G., Maciejewska, M. and Górski, A. (2009) The effect of bacteriophages T4 and HAP1 on in vitro melanoma migration. BMC Microbiology 9, 13.
18. Dabrowska, K., Skaradziński, G., Kurzepa, A., Owczarek, B., Zaczek, M., Weber-Dabrowska, B., Wietrzyk, J., Maciejewska, M., Budynek, P. and Górski, A. (2010) The effects of staphylococcal bacteriophage lysates on cancer cells in vitro. Clinical and Experimental Medicine 10, 81-85.
19. Dean, J.H., Silva, J.S., McCoy, J.L., Chan, S.P., Baker, J.J., Leonard, C. and Herberman, R.B. (1975) In vitro human reactivity to staphylococcal phage lysate. Journal of Immunology 115, 1060-1064.
20. Dubos, R.J., Straus, J.H. and Pierce, C. (1943) The multiplication of bacteriophage in vivo and its protective effect against an experimental infection with Shigella dysenteriae. Journal of Experimental Medicine 20, 161-168.
21. Duerr, D.M., White, S.J. and Schluesener, H.J. (2004) Identification of peptide sequences that induce the transport of phage across the gastrointestinal mucosal barrier. Journal of Virological Methods 116, 177-180.
22. Esber, H.J., DeCourcy, J. and Bogden, A.E. (1981) Specific and nonspecific immune resistance enhancing activity of staphage lysate. Journal of Immunopharmacology 3, 79-92.
23. Esber, H.J., Ganfield, D. and Rosenkrantz, H. (1985) Staphage lysate: an immunomodulator of the primary immune response in mice. Immunopharmacology 10, 77-82.
24. Fokine, A., Chipman, P.R., Leiman, P.G., Mesyanzhinov, V.V., Rao, V.B. and Rossmann, M.G. (2004) Molecular architecture of the prolate head of bacteriophage T4. Proceedings of the National Academy of Sciences USA 101, 6003-6008.
25. Fraser, J.S., Yu, Z., Maxwell, K.L. and Davidson, A.R. (2006) Ig-like domains on bacteriophages: a tale of promiscuity and deceit. Journal of Molecular Biology 359, 496-507.
26. Geier, M.R., Trigg, M.E. and Merril, C.R. (1973) Fate of bacteriophage lambda in non-immune germfree mice. Nature 246, 221-223.
27. Giancotti, F.G. and Ruoslahti, E. (1999) Integrin signaling. Science 285, 1028-1032.
28. Gorczyca, W.A., Mitkiewicz, M., Siednienko, J., Kurowska, E., Piasecki, E., Weber-Dabrowska, B. and Górski, A. (2007) Bacteriophages decrease activity of NF-κb induced in human mononuclear cells by Human Herpesvirus-1. In: Kalil, J., Neto-Cunha, E. and Rizzo, L.V. (eds) Proceedings of 13th International Congress of Immunology. MEDIMOND S.r.l., Rio de Janeiro, Brazil, pp. 73-77.
29. Górski, A. and Weber-Dabrowska, B. (2005) The potential role of endogenous bacteriophages in controlling invading pathogens. Cellular and Molecular Life Sciences 62, 511-519.
30. Górski, A., Dabrowska, K., Świtała-Jeleń, K., Nowaczyk, M., Weber-Dabrowska, B., Boratyński, J., Wietrzyk, J. and Opolski, A. (2003a) New insights into the possible role of bacteriophages in host defense and disease. Medical Immunology 2, 2.
31. Górski, A., Nowaczyk, M., Weber-Dabrowska, B., Kniotek, M., Boratyński, J., Achmed, A., Dabrowska, K., Wierzbicki, P., Świtała-Jeleń, K. and Opolski, A. (2003b) New insights into the possible role of bacteriophages in transplantation. Transplantation Proceedings 35, 2372-2373.
32. Górski, A., Kniotek, M., Perkowska-Ptasińska, A., Mróz, A., Przerwa, A., Gorczyca, W., Dabrowska, K., Weber-Dabrowska, B. and Nowaczyk, M. (2006a) Bacteriophages and transplantation tolerance. Transplantation Proceedings 38, 331-333.
33. Górski, A., Wazna, E., Weber-Dabrowska, B., Dabrowska, K., Świtała-Jeleń, K. and Miedzybrodzki, R. (2006b) Bacteriophage translocation. FEMS Immunology and Medical Microbiology 46, 313-319.
34. Górski, A., Miedzybrodzki, R., Borysowski, J., Weber-Dabrowska, B., Łobocka, M., Fortuna, W., Letkiewicz, S., Zimecki, M. and Filby, G. (2009) Bacteriophage therapy for the treatment of infections. Current Opinion in Investigational Drugs 10, 766-774.
35. Gulam, W. and Ahsan, H. (2006) Reactive oxygen species: role in the development of cancer and various chronic conditions. Journal of Carcinogenesis 5, 14.
36. Harrath, R., Bourlet, T., Delézay, O., Douche-Aourik, F., Omar, S., Aouni, M. and Pozzetto, B. (2004) Coxsackievirus B3 replication and persistence in intestinal cells from mice infected orally and the human CaCo-2 cell line. Journal of Medical Virology 74, 283-290.
37. Hiscott, J., Beauparlant, P., Crepieux, P., DeLuca, C., Kwon, H., Lin, R. and Petropoulos, L. (1997) Cellular and viral protein interactions regulating IκBα activity during human retrovirus infection. Journal of Leukocyte Biology 62, 82-92.
38. Horst, D., Verweij, M.C., Davison, A.J., Ressing, M.E. and Wiertz, E.J.H.J. (2011) Viral evasion of T cell immunity: ancient mechanisms offering new applications. Current Opinion in Immunology 23, 96-103.
39. Housby, J.N. and Mann, N.H. (2009) Phage therapy. Drug Discovery Today 14, 536-540.
40. Inchley, C.J. (1969) The activity of mouse Kupffer cells following intravenous injection of T4 bacteriophage. Clinical and Experimental Immunology 5, 173-187.
41. Ishii, T. and Yanagida, M. (1975) Molecular organization of the shell of the T-even bacteriophage head. Journal of Molecular Biology 97, 655-660.
42. Ishii, T. and Yanagida, M. (1977) The two dispensable structural proteins (soc and hoc) of the T4 phage capsid; their purification and properties, isolation and characterization of the defective mutants, and their binding with the defective heads in vitro. Journal of Molecular Biology 109, 487-514.
43. Kańtoch, M. (1958) Studies on phagocytosis of bacterial viruses. Archivum Immunologiae et Therapiae Experimentalis 6, 63-84 (in Polish).
44. Kańtoch, M. and Mordarski, M. (1958) Binding of bacterial viruses by cancer cells in vitro. Postepy Higieny i Medycyny Doświadczalnej 12, 191-192 (in Polish).
45. Keller, R. and Engley, F.B. (1958) Fate of bacteriophage particles introduced into mice by various routes. Proceedings of the Society for Experimental Biology and Medicine 98, 557-580.
46. Kiliç, A.O., Pavlova, S.I., Ma, W. and Tao, L. (1996) Analysis of Lactobacillus phages and bacteriocins in American dairy products and characterization of a phage isolated from yogurt. Applied and Environmental Microbiology 62, 2111-2116.
47. Kleinschmidt, W.J., Douthardt, R.J. and Murphy, E.B. (1970) Interferon production by T4 coliphage. Nature 228, 27-30.
48. Knight, J.A. (1995) Diseases related to oxygenderived free radicals. Annals of Clinical and Laboratory Science 25, 111-121.
49. Kniotek, M., Ahmed, A.M.A., Dabrowska, K., Świtała-Jeleń, K., Weber-Dabrowska, B., Boratyński, J., Nowaczyk, M., Opolski, A. and Górski, A. (2004a) Bacteriophage interactions with T cells and platelets. In: Monduzzi Editore, Genomic Issues, Immune System Activation and Allergy (Immunology 2004). Medimond International Proceedings, Montreal, Canada, pp. 189-193.
50. Kniotek, M., Weber-Dabrowska, B., Dabrowska, K., Świtała-Jeleń, K., Boratyński, J., Wiszniowski, M., Glinkowski, W., Babiak, I., Górecki, A., Nowaczyk, M. and Górski, A. (2004b) Phages as immunomodulators of antibody production. In: Monduzzi Editore, Genomic Issues, Immune System Activation and Allergy (Immunology 2004). Medimond International Proceedings Montreal, Canada, pp. 33-37.
51. Kucharewicz-Krukowska, A. and Ślopek, S. (1987) Immunogenic effect of bacteriophage in patients subjected to phage therapy. Archivum Immunologiae et Therapiae Experimentalis 35, 553-561.
52. Kumari, S., Harjai, K. and Chhibber, S. (2010) Evidence to support the therapeutic potential of bacteriophage Kpn5 in burn wound infection caused by Klebsiella pneumoniae in BALB/c mice. Journal of Microbiology and Biotechnology 20, 935-941.
53. Kurzepa, A., Dabrowska, K., Skaradziński, G. and Górski, A. (2009) Bacteriophage interactions with phagocytes and their potential significance in experimental therapy. Clinical and Experimental Medicine 9, 93-100.
54. Lafrenie, R.M., Lee, S.F., Hewlett, I.K., Yamada, K.M. and Dhawan, S. (2002) Involvement of integrin αvβ3 in the pathogenesis of human immunodeficiency virus type 1 infection in monocytes. Virology 297, 31-38.
55. Langbeheim, H., Teitelbaum, D. and Arnon, R. (1978) Cellular immune response toward MS-2 phage and a synthetic fragment of its coat protein. Cellular Immunology 38, 193-197.
56. Lu, Z., Breidt, F., Plengvidhya, V. and Fleming, H.P. (2003) Bacteriophage ecology in commercial sauerkraut fermentations. Applied and Environmental Microbiology 79, 3192-3202.
57. Mathur, A., Narayanan, K., Zerbe, A., Ganfield, D., Ramasastry, S.S. and Futrell, J.W. (1988) Immunomodulation of intradermal mammary carcinoma using staphage lysate in a rat model. Journal of Investigative Surgery 1, 117-123.
58. Merril, C.R. (1974) Bacteriophage interactions with higher organisms. Transactions of the New York Academy of Sciences 36, 265-272.
59. Merril, C.R., Friedman, T.B., Attallah, A.F.M., Geier, M.R., Krell, K. and Yarkin, R. (1972) Isolation of bacteriophages from commercial sera. In Vitro 8, 91-93.
60. Merril, C.R., Biswas, B., Carlton, R., Jensen, N.C., Creed, G.J., Zullo, S. and Adhya, S. (1996) Long-circulating bacteriophage as antibacterial agents. Proceedings of the National Academy of Science USA 93, 3188-3192.
61. Miedzybrodzki, R., Świtała-Jeleń, K., Fortuna, W., Weber-Dabrowska, B., Przerwa, A., Łusiak-Szelachowska, M., Dabrowska, K., Kurzypa, A., Boratyński, J., Syper, D., Poźniak, G., Ługowski, C. and Górski, A. (2008) Bacteriophage preparation inhibition of reactive oxygen species generation by endotoxin-stimulated polymorphonuclear leukocytes. Virus Research 131, 233-242.
62. Miedzybrodzki, R., Fortuna, W., Weber-Dabrowska, B. and Górski, A. (2009) A retrospective analysis of changes in inflammatory markers in patients treated with bacterial viruses. Clinical and Experimental Medicine 9, 303-312.
63. Morello, E., Saussereau, E., Maura, D., Huerre, M., Touqui, L. and Debarbieux, L. (2011) Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and prevention. PLoS ONE 6, 1-9.
64. Morin, M.J. and Warner, A. (1994) A pathway for entry of reoviruses into the host through M cells of the respiratory tract. Journal of Experimental Medicine 180, 1523-1527.
65. Mossel, E.C. and Ramig, R.F. (2003) A lymphatic mechanism of rotavirus extraintestinal spread in the neonatal mouse. Journal of Virology 77, 12352-12356.
66. Nelson, R. (2003) Antibiotic development pipeline runs dry. Lancet 362, 1726-1727.
67. O'Boyle, C., MacFie, J., Mitchell, C., Johnstone, D., Sagar, P. and Sedman, P. (1998) Microbiology of bacterial translocation in humans. Gut 42, 29-35.
68. Ochs, H.D., Davis, S.D. and Wedgwood, R.J. (1971) Immunologic responses to bacteriophage φX174 in immunodeficiency diseases. Journal of Clinical Investigation 50, 2559-2568.
69. Olszewska, D. and Radkowski, H. (2005) Odporność przeciwzakaźna. In: Gołab, J., Jakóbisiak, M. and Lasek, W. (eds) Immunologia. Wydawnictwo Naukowe PWN, Warszawa, pp. 337-355.
70. Orr, H.C., Sibinovic, K.H., Probst, P.G., Hochstein, D. and Littlejohn, D.C. (1975) Bacteriological activity in unfiltered calf sera collected for tissue culture use. In Vitro 11, 230-233.
71. Pagava, K., Gachechiladze, K., Korinteli, I., Dzuliashvili, M., Alavidze, Z., Hoyle, N. and Metskhvarishvili, G. (2011) What happens when the child gets bacteriophage per os? Georgian Medical News 196-197, 101-105.
72. Parent, K. and Wilson, I.D. (1971) Mycobacteriophage in Crohn's disease. Gut 12, 1019-1020.
73. Perdih, A. and Dolenc, M.S. (2010) Small molecule antagonists of integrin receptors. Current Medical Chemistry 17, 2371-2392.
74. Pescovitz, M.D., Torgerson, T.R., Ochs, H.D., Ocheltree, E., McGee, P., Krause-Steinrauf, H., Lachin, J.M., Canniff, J., Greenbaum, C., Herold, K.C., Skyler, J.S., Weinberg, A. and the Type 1 Diabetes TrialNet Study Group (2011) Effect of rituximab on human in vivo antibody immune responses. Journal of Allergy and Clinical Immunology 128, 1295-1302.e5.
75. Ploegh, H.L. (1998) Viral strategies of immune evasion. Science 280, 248-253.
76. Przerwa, A., Kniotek, M., Nowaczyk, M., Weber-Dabrowska, B., Świtała-Jeleń, K., Dabrowska, K. and Górski, A. (2005) Bacteriophages inhibit interleukin-2 production by human T lymphocytes. In: 12th Congress of the European Society for Organ Transplantation, Geneva, Switzerland.
77. Przerwa, A., Zimecki, M., Świtała-Jeleń, K., Dabrowska, K., Krawczyk, E., Łuczak, M., Weber-Dabrowska, B., Syper, D., Miedzybrodzki, R. and Górski, A. (2006) Effects of bacteriophages on free radical production and phagocytic functions. Medical Microbiology and Immunology 195, 143-150.
78. Sathaliyawala, T., Islam, M.Z., Li, Q., Fokine, A., Rossmann, M.G. and Rao, V.B. (2010) Functional analysis of the highly antigenic outer capsid protein, Hoc, a virus decoration protein from T4-like bacteriophages. Molecular Microbiology 77, 444-455.
79. Sikora, J.P. (2002) Immunotherapy in the management of sepsis. Archivum Immunologiae et Therapiae Experimentalis 50, 317-324.
80. Ślopek, S., Durlakowa, I., Weber-Dabrowska, B., Kucharewicz-Krukowska, A., Dabrowski, M. and Bisikiewicz, R. (1983) Results of bacteriophage treatment of suppurative bacterial infections. Archivum Immunologiae et Therapiae Experimentalis 31, 267-291.
81. Smith, P.D., Meng, G., Salazar-Gonzalez, J.C. and Shaw, G.M. (2003) Macrophage HIV-1 infection and the gastrointestinal tract reservoir. Journal of Leukocyte Biology 74, 642-649.
82. Srivastava, A.S., Kaido, T. and Carrier, E. (2004) Immunological factors that affect the in vivo fate of T7 phage in the mouse. Journal of Virological Methods 115, 99-104.
83. Sulakvelidze, A. and Kutter, E. (2005) Bacteriophage therapy in humans. In: Sulakvelidze, A. and Kutter, E. (eds) Bacteriophages: Biology and Application. CRC Press, Boca Raton, FL, pp. 381-436.
84. Triantafilou, K., Takada, Y. and Traintafilou, M. (2001) Mechanisms of integrin-mediated virus attachment and internalization process. Critical Reviews in Immunology 21, 311-322.
85. Varon, D. and Shai, E. (2009) Role of platelet-derived microparticles in angiogenesis and tumor progression. Discovery Medicine 8, 237-241.
86. Weber-Dabrowska, B., Dabrowska, M. and Ślopek, S. (1987) Studies on bacteriophage penetration in patients subjected to phage therapy. Archivum Immunologiae et Therapiae Experimentalis 35, 563-568.
87. Weber-Dabrowska, B., Mulczyk, M. and Górski, A. (2000a) Bacteriophage therapy of bacterial infections: an update of our institute's experience. Archivum Immunologiae et Therapiae Experimentalis 48, 547-551.
88. Weber-Dabrowska, B., Zimecki, M. and Mulczyk, M. (2000b) Effective phage therapy is associated with normalization of cytokine production by blood cell cultures. Archivum Immunologiae et Therapiae Experimentalis 48, 31-37.
89. Weber-Dabrowska, B., Zimecki, M., Muczyk, M. and Górski, A. (2002) Effect of phage therapy on the turnover and function of peripheral neutrophils. FEMS Immunology and Medical Microbiology 34, 135-138.
90. Weber-Dabrowska, B., Mulczyk, M. and Górski, A. (2003) Bacteriophages as an efficient therapy for antibiotic-resistant septicemia in man. Transplantation Proceedings 35, 1385-1386.
91. Weinbauer, M.G. (2004) Ecology of prokaryotic viruses. FEMS Microbiology Reviews 28, 127-181.
92. Wenger, S.L., Turner, J.H. and Petricciani, J.C. (1978) The cytogenic, proliferative and viability effects of four bacteriophages on human lymphocytes. In Vitro 14, 543-549.
93. Wierzbicki, P., Kłosowska, D., Wyzgał, J., Nowaczyk, M., Przerwa, A., Kniotek, M. and Górski, A. (2006) β3 integrin expression on T cells from renal allograft recipients. Transplantation Proceedings 38, 338-339.
94. Wiest, R. and Garcia-Tsao, G. (2005) Bacterial translocation (BT) in cirrhosis. Hepatology 41, 422-430.